Andreucci Carla Betina, Filippi Veronique, Cecatti Jose Guilherme
Department of Medicine, Federal University of Sao Carlos, Sao Carlos, Brazil
Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
BMJ Open. 2021 Feb 5;11(2):e042667. doi: 10.1136/bmjopen-2020-042667.
The 2016 WHO antenatal guidelines propose evidence-based recommendations to improve maternal outcomes. We aim to complement these recommendations by describing and estimating the effects of the interventions recommended by WHO on maternal well-being or functioning.
We will conduct a systematic review of experimental and quasi-experimental studies evaluating women's well-being or functioning following the implementation of evidence-based antenatal interventions, published in peer-reviewed journals through a 15-year interval (2005-2020). The lead reviewer will screen all records identified at MEDLINE, EMBASE, CINAHL Plus, LILACS and SciELO. Two other reviewers will control screening strategy quality. Quality and risk of bias will be assessed using a specially designed instrument. Data synthesis will consider the instruments applied, how often they were used, conditions/interventions for positive or negative effects documented, statistical measures used to document effectiveness and how results were presented. A random-effects meta-analysis comparing frequently used instruments may be conducted.
The study will be a systematic review with no human beings' involvement, therefore not requiring ethical approval. Findings will be disseminated through peer-reviewed publication and scientific events.
CRD42019143436.
2016年世界卫生组织(WHO)的产前指南提出了基于证据的建议以改善孕产妇结局。我们旨在通过描述和评估WHO所推荐的干预措施对孕产妇幸福感或功能的影响来补充这些建议。
我们将对评估循证产前干预措施实施后女性幸福感或功能的实验性和准实验性研究进行系统综述,这些研究发表于同行评审期刊,时间跨度为15年(2005 - 2020年)。首席评审员将筛选在MEDLINE、EMBASE、CINAHL Plus、LILACS和SciELO中检索到的所有记录。另外两名评审员将把控筛选策略的质量。将使用专门设计的工具评估质量和偏倚风险。数据合成将考虑所应用的工具、其使用频率、记录的正面或负面影响的条件/干预措施、用于记录有效性的统计方法以及结果的呈现方式。可能会进行一项比较常用工具的随机效应荟萃分析。
该研究将是一项无人类参与的系统综述,因此无需伦理批准。研究结果将通过同行评审发表和科学活动进行传播。
PROSPERO注册号:CRD42019143436。